STOCK TITAN

Bioventus to Release Third Quarter of Fiscal Year 2021 Financial Results on November 9, 2021

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Bioventus (Nasdaq: BVS) will release its third quarter fiscal year 2021 financial results on November 9, 2021, before market opening. The company will host a conference call at 8:30 a.m. ET to discuss these results and offer a business update. Participants can join by dialing 844-945-2085, with an international dial-in option available. A live webcast will also be accessible on the company's investor relations website and will be archived for future reference until November 9, 2022.

Positive
  • None.
Negative
  • None.

DURHAM, N.C., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that third quarter of fiscal year 2021 financial results will be released before the market opens on Tuesday, November 9, 2021.

Management will host a conference call to discuss its financial results and provide a business update, with a question and answer session, at 8:30 a.m. Eastern Time on November 9, 2021. Those who would like to participate may dial 844-945-2085 (442-268-1266 for international callers) and provide access code 9652759. A live webcast of the call and any accompanying materials will also be provided on the investor relations section of the Company's website at https://ir.bioventus.com/.

The webcast will be archived on the Company’s website at https://ir.bioventus.com/ and available for replay until November 9, 2022.

About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for pain treatment, restorative therapies and bone graft substitutes. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

Investor Inquiries:
Dave Crawford
919-474-6787
Dave.Crawford@bioventus.com  

Media Contact:
Thomas Hill
919-474-6715
thomas.hill@bioventusglobal.com


FAQ

What date will Bioventus release its third quarter 2021 financial results?

Bioventus will release its third quarter 2021 financial results on November 9, 2021.

When is the Bioventus conference call to discuss financial results?

The conference call will take place at 8:30 a.m. ET on November 9, 2021.

How can I access the Bioventus financial results conference call?

You can access the call by dialing 844-945-2085 or by joining the live webcast on the investor relations website.

Where can I find the archived Bioventus conference call?

The archived conference call will be available on the Bioventus investor relations website until November 9, 2022.

Bioventus Inc.

NASDAQ:BVS

BVS Rankings

BVS Latest News

BVS Stock Data

758.45M
65.19M
11.51%
65.44%
2.65%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
DURHAM